최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.41 no.5, 2020년, pp.787 - 799
전상우 (우석대학교 한의과대학 한방내과학교실) , 강세영 (우석대학교 한의과대학 한방내과학교실)
Objectives: Pityriasis rubra pilaris (PRP) is a rare papulosquamous disorder with unknown etiology. Studies on adults have not been conducted yet in Korean medicine. We report the progress of Korean medicine treatment for adult-type pityriasis rubra pilaris. Methods: A 62-year-old female patient was...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
모공성 홍색 비강진이란 무엇인가? | 모공성 홍색 비강진(pityriasis rubra pilaris, PRP)은 작은 모낭 구진과 황홍색의 파종상의 인설 및 손발바닥의 과각화증을 특징으로 하는 만성적인 피부질환이다1. PRP는 비교적 드문 피부질환에 속하며, 5,000명 중 1명 꼴로 이환된다고 알려져 있다2. | |
PRP의 일반적인 치료법은 무엇인가? | 그 외에도 바이러스 감염설이 있는데, PRP 병발 후 human immunodeficiency virus(HIV) 환자에서 HIV의 치료와 예후에 따라 피부증상의 변화가 보이므로 바이러스가 관계된다는 보고가 있다1. PRP의 일반적인 치료법은 국소적 요법으로 각질용해제나 피부 연화제 등이 쓰이며, 전신요법으로 비타민A 경구 투여, 면역억제제인 methotrexate 등이 쓰이고 있다. 그러나 치료법의 개인간 편차가 크며, 대부분이 장기간 사용을 필요로 하며 부작용의 위험이 있어 어려움을 겪고 있다1,3. | |
모공성 홍색 비강진의 원인은 무엇인가? | PRP는 비교적 드문 피부질환에 속하며, 5,000명 중 1명 꼴로 이환된다고 알려져 있다2. PRP의 원인은 아직 확실히 밝혀진 바는 없으며, 비타민A의 결핍 혹은 바이러스 감염과 관계된다고 알려져 있다. 비타민A 결핍증 환자와 유사한 피부 양상을 보여 비타민A 결핍증 혹은 비정상적 비타민A 대사와 관련 있는 것으로 생각된다. 그 외에도 바이러스 감염설이 있는데, PRP 병발 후 human immunodeficiency virus(HIV) 환자에서 HIV의 치료와 예후에 따라 피부증상의 변화가 보이므로 바이러스가 관계된다는 보고가 있다1. PRP의 일반적인 치료법은 국소적 요법으로 각질용해제나 피부 연화제 등이 쓰이며, 전신요법으로 비타민A 경구 투여, 면역억제제인 methotrexate 등이 쓰이고 있다. |
Korean Dermatological Society Textbook Compilation Committee. Text of Dermatology. 6th editon. Seoul: Sungbo Medical booke store; 2014, p.316-8.
Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol 1980;5(1):105-12.
Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010;11(3):157-70.
Christian K, Robert S, Daniel C, Rotraut M. Systemic therapies of Pityriasis rubra pilaris: a systematic review. Treatment of Pityriasis rubra pilaris type I: a systematic review Pityriasis rubra pilaris--a retrospective single center analysis over eight years. J Dtsch Dermatol Ges 2019;17(3):243-59.
Jeong JT, Kye YC, Kim SN. A Clinical and Histopathologic Study of Pityriasis rubra pilaris. Ann Dermatol 2002;40(4):363-74.
Sim SY. A Case of Honyoja : Pityriasis rubra pilaris with good response to Korean Medicine. J Korean Med Ophthalmol Otolaryngol Dermatol 2015;28(4):215-20.
Tarral C Observation CXVIIII In: Rayer P, ed. Traite theorique et pratique des maladies de la peau. Vol 2. Paris: Bailliere; 1835, p. 158-9.
Devergie A. Traite pratique des maladies de la peau. Paris: Masson; 1857, p. 454-64.
Besnier E. Observation pour server a historic clinique du, Pityriasis rubra pilaris. Am Dermatol Syphil 1889;10:253-87.
Griffiths WA. Pityriasis rubra pilaris: the problem of its classification. J Am Acad Dermatol 1992;26(1):140-2.
Tarral C. General psoriasis-desquamation from the parts covered by hair. In: Rayer P, editor. A theoretical and practical treatise on the diseases of the skin. 2nd ed. London: Baillere 1835, p. 648-9.
Griffiths WA, Judge MR, Leigh IM. Disorders of keratinization-Pityriasis rubra pilaris. In: Champion RH, Burton JL, Burns DA, et al, editors. Text Book of dermatology. 6th ed. London: lackwell Science; 1988, p. 1539-45.
Gold Smith LA, Baden HP. Pityriasis rubra pilaris. In: Freeberg IM, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. Vol 1 6th ed. London: Mc-Graw Hill Publication; 2003, p. 442-4.
Mortimer PS, Dawber RP. Dermatologic disease of the nail unit other than psoriasis and lichen planus. Dermatol Clin 1985;3(3):401-7.
Lambert DG, Dalac S. Nail changes in type 5 Pityriasis rubra pilaris. J Am Acad Dermatol 1989;21(4Pt1):811-2.
Sehgal VN, Srivastav G. (Juvenile) Pityriasis rubra pilaris. Int J Dermatol 2006;45(4):438-46.
Bragg J, Witkiewicz A, Orlow SJ, Schaffer JV. Pityriasis rubra pilaris, type IV. Dermatol Online J 2005;11(4):14.
Caldarola G, Zampetti A, De Simone C, Massi G, Amerio P, Feliciani C. Circumscribed Pityriasis rubra pilaris type IV. Clin Exp Dermatol 2007;32(4):471-2.
Misery I, Faure M, Claidy A. Pityriasis rubra pilaris and human immunodeficiency virus infection-type 6 Pityriasis rubra pilaris? Br J Dermatol 1996;135(6):1008-9.
Fung PM. Pityriasis rubra pilaris: an Update Review. Hong Kong J Dermatol 2001;9(1):10-6.
Soeprono FF. Histologic criteria for the diagnosis of Pityriasis rubra pilaris. Am J Dermatopathol 1986;8(4):277-83.
Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010;11(3):157-70.
Eastham AB, Femia AN, Qureshi A, Vleugels RA. Treatment options for Pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center. JAMA Dermatol 2014;150(1):92-4.
Gemmeke A, Schonlebe J, Koch A, Wollina U. Pityriasis rubra pilaris - a retrospective single center analysis over eight years. J Dtsch Dermatol Ges 2010;8(6):439-44.
Goldsmith LA, Weinrich AE, Shupack J. Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J Am Acad Dermatol 1982;6(4pt2suppl):710-5.
Dicken CH. Treatment of classic Pityriasis rubra pilaris. J Am Acad Dermatol 994;31(6):997-9.
Molin S, Ruzicka T. Treatment of refractory Pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol 2010;163(1):221-3.
Schmitt L, Inhoff O, Dippel E. Oral alitretinoin for the treatment of recalcitrant Pityriasis rubra pilaris. Case Rep Dermatol 2011;3(1):85-8.
Amann PM, Susic M, Gluder F, Berger H, Krapf W, Loffler H. Alitretinoin (9-cis retinoic acid) is effective against Pityriasis rubra pilaris: a retrospective clinical study. Acta Derm Venereol 2015;95(3):329-31.
Pampin A, Gomez-de la Fuente E, Caro Gutierrez MD, Lopez-Estebaranz JL. Successful treatment of atypical adult Pityriasis rubra pilaris with oral alitretinoin. J Am Acad Dermatol 2013;69(2):105-6.
Kromer C, Sabat R, Celis D, Mossner R. Systemic therapies of Pityriasis rubra pilaris: a systematic review. J Dtsch Dermatol Ges 2019;17(3):243-59.
Moretta G, De Luca EV, Di SA. Management of refractory Pityriasis rubra pilaris: challenges and solutions. Clin Cosmet Investig Dermatol 2017;9(10):451-7.
Hsu DC, Katelaris CH. Long-term management of patients taking immunosuppressive drugs. Aust Prescr 2009;32(3):68-71.
Muhammad Y, Amandeep G, Pankaj B, Sidharth S. "Corticosteroid Adverse Effects" July 4, 2020. https://www.ncbi.nlm.nih.gov/books/NBK531462/.
Wang CX. Experience of TCM differentiation and treatment of pityriasis pilaris. Journal of Sichuan Traditional Chinese Medicine 2009;27(5):35.
Yang Z, Cai NN. Current status of TCM treatment of Pityriasis rubra pilaris. JBUTCM 2006;13(6):45-6.
Ma JM, Zhang YF. Pityriasis rubra pilaris. Shandong Journal of Traditional Chinese Medicine 1993;13(5):49.
Department of Sasang constitutional medicine, Collage of national Korean medicine. Sasang constitutional medicine(Revised supplement). Seoul: Jipmoondang; 2016, p. 670, 692 710-11, 723
Son JM, Choi IH. A Literature Study about the Correlation between Genetic Studies on Atopic Dermatitis, Sasang Constitution, and Sasang Constitutional Study on Atopic Dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol 2005;18(2):1-9.
Park HS, Joo JC, Lee EJ. Clinical Practice Guideline for Taeyangin Disease of Sasang Constitutional Medicine. J Sasang Constitut Med 2015;27(1):71-81.
Song DU, Min GY, Hong SY, Lim SE, Huh J, Sohn YJ, et al. Effects of KMS on the DNCB induced animal Model of Atopic Dermartitis. J Korean Med 2019;40(1):63-77.
Kim YJ, Song CH. Anti-Inflammatory Effect of Bower Actinidia in LPS-Stimulated RAW264.7 Cells. Korean Journal of Acupuncture 2013;30(4):243-51.
Kim YH, Park YS. Effect of Acanthopanacis cortex Water Extract on Antioxidative Activity, Lipid Profile and Epidermal Thickness in DNCB-induced Allergic Contact Dermatitis Animal Model. Korean J Food Sci Technol 2006;38(5):668-73.
An SM, Kim HG, Choi EJ, Hwang HH, Lee ES, Baek JH, et al. Screening for Anti-inflammatory Activities in Extracts from Korean Herb Medicines. J Soc Cosmet Scientists Korea 2014;40(1):95-108.
Kim HS, Jeon IH, Mok JY, Kang HJ, Jang SI. Antipruritic Effects of Ethanol Extracts from Perillae Japonicae Semen leaves and Chaenomelis Fructus. J Physiol & Pathol Korean Med 2012;26(3):314-9.
Fuchs-Telem D, Sarig O, van Steensel MA, Isakov O, Israeli S, Nousbeck J, et al. Familial Pityriasis rubra pilaris Is Caused by Mutations in CARD14. Am J Hum Genet 2012;91(1):163-70.
Koch L, Schoffl C, Aberer W, Massone C. Methotrexate treatment for Pityriasis rubra pilaris: a case series and literature review. Acta Derm Venereol 2018;98(5):501-5.
Parna E, Aluoja A, Kingo K. Quality of life and emotional state in chronic skin disease. Acta Derm Venereol 2015;95(3):312-6.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.